April price cut to wipe $7bn off Japanese drug market
This article was originally published in Scrip
Executive Summary
The next biennial revision of drug reimbursement prices in Japan in April will slash around ¥550 billion ($7 billion) from the nation's medicines budget, a saving that will be used to balance out planned increases in medical fees.